Tumor dynamics model with treatments by oncolytic virotherapy and MEK inhibitors involving TNF-α inhibitors: Stability analysis and optimal control
Oncolytic virotherapy is one of the cancer treatments that kills cancer cells but leaves normal cells. Furthermore, mitogen-activated protein kinase (MEK) inhibitors boost chimeric antigen receptor expression and increase oncolytic virus entry into tumor cells, and TNF-α{\rm{\alpha }} inhibitors imp...
Saved in:
| Main Authors: | Daengkongkho Salinthip, Viriyapong Ratchada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-08-01
|
| Series: | Computational and Mathematical Biophysics |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/cmb-2025-0025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01) -
Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma—a promising innovative approach
by: Benjamin Gesundheit, et al.
Published: (2025-08-01) -
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines
by: Hyun-Min Ryu, et al.
Published: (2025-08-01) -
Almost global well-posedness for quasilinear strongly coupled wave-Klein-Gordon systems in two space dimensions
by: Mihaela Ifrim, et al.
Published: (2025-01-01) -
Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential
by: Aditi Gupta, et al.
Published: (2025-08-01)